title: A tight glycemic control initiative in a surgical intensive care unit and hospitalwide.
abstract: BACKGROUND
  In 2002, tight glycemic control (TGC) was mandated at Henry Ford Hospital (Detroit) to reduce surgical site infections (SSIs). THE FIVE STEPS FOR IMPROVEMENT: The TGC initiative was developed in terms of the five primary steps of the Institute for Healthcare Improvement (IHI) framework for leadership for improvement to drive practice change and maintain continuous improvement. In terms of Steps 1-3 (set direction, establish the foundation, and build will), in April 2002 the chief executive officer of the Henry Ford Hospital (Detroit) announced a hospitalwide initiative to reduce SSIs. For steps 4 and 5 (generate ideas and execute change), the 40-bed surgical intensive care unit (SICU) was designated the practice-change setting. TGC protocols were implemented in cardiothoracic patients, followed by all SICU patients, with target glucose ranges moving from the initial < 150 mg/dL to 80-110 mg/dL. Results showed decreases in SSIs and mortality. The project's success led initiation of hospitalwide TGC in the next two years. RESPONDING TO A CHANGING EVIDENCE BASE: In 2009, as studies began to show that the recommended glucose target of 80-110 mg/dL was not associated with clinical improvement in ICU patients and perhaps may cause harm (increased mortality), the target ranges were modified.
  
  
  CONCLUSIONS
  Barriers to adoption of new practice change must be integrated into the planning process. Leadership champions are required across multiple levels of the organization to drive change to the bedside for effective and lasting improvement.
  
  
  CONCLUSIONS
  A universal TGC protocol continues to be used throughout the hospital, with modifications and next-generation improvements occurring as evidence arises.
authors.affiliation: Department of Surgery, Henry Ford Hospital, Detroit, USA. mhorst1@hfhs.org
authors.forename: H Mathilda
authors.initials: HM
authors.lastname: Horst
authors.forename: Ilan
authors.initials: I
authors.lastname: Rubinfeld
authors.forename: Mark
authors.initials: M
authors.lastname: Mlynarek
authors.forename: Mary-Margaret
authors.initials: MM
authors.lastname: Brandt
authors.forename: Gail
authors.initials: G
authors.lastname: Boleski
authors.forename: Jack
authors.initials: J
authors.lastname: Jordan
authors.forename: Gwen
authors.initials: G
authors.lastname: Gnam
authors.forename: William
authors.initials: W
authors.lastname: Conway
mesh_terms: D001786:Blood Glucose; D002985:Clinical Protocols; D006801:Humans; D007362:Intensive Care Units / Q000458:organization & administration*; D007857:Leadership; D010348:Patient Care Team / Q000458:organization & administration; D011182:Postoperative Care / Q000379:methods*; D017064:Process Assessment, Health Care / Q000458:organization & administration; D011785:Quality Assurance, Health Care / Q000458:organization & administration*
chemical_list: D001786:Blood Glucose